C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is characterised by accelerated lipid deposition, aberrant inflammation, and excessive extracellular matrix production in the liver. Short of effective intervention, NAFLD can progress to cirrhosis and hepatocellular carcinoma. In...

Full description

Bibliographic Details

Published in:	JHEP Reports
Main Authors:	Zhiwen Fan, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Yong Xu, Jie Li, Xiaoping Zou, Zilong Li
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Subjects:	Non-alcoholic fatty liver disease Hepatocytes Transcriptional regulation Chemokine Inflammation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555923001362